While weight loss itself is associated with a reduction in inflammatory markers, GLP-1 medications are not
These include: Nausea (the most common complaint, particularly in the first few weeks) Vomiting Diarrhoea or constipation Decreased appetite (which, while therapeutically desirable, can occasionally be excessive) Abdominal discomfort or bloating Injection-site reactions (such as redness, itching, or mild swelling at the injection site) Headache, dizziness, and fatigue , particularly during early treatment These effects are generally dose-dependent and tend to diminish as the body adjusts to the medication
The compounds approximately 6-day half-life supports this retatrutide dosing frequency and allows steady-state plasma concentrations to be reached within 45 weeks
In addition to our wide range of aesthetic treatments, we are pleased to introduce GLP-1 medications, such as Ozempic ( semaglutide GLP-1), as part of our medical weight management program
Hvordan bruger man GLP-1 til vgttab
contrastingly, PARP-1 treatment promoted PARP-1 phosphorylation while it decreased ABCA1 protein level upon cholesterol stimulation
